http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101514320-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D273-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2013-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101514320-B1 |
titleOfInvention | Novel pharmaceutical composition for preventing or treating cancer |
abstract | The present invention relates to a novel anticancer composition, and more particularly, to a pharmaceutical composition comprising a compound represented by the general formula (1). Since the compound of the present invention inhibits the protein level of AIMP2-DX2 which is overexpressed in lung cancer cells in a concentration-dependent manner and does not act on normal cells and inhibits the survival of cancer cells in a concentration-dependent manner, the compound of the present invention or its pharmaceutically acceptable A pharmaceutical composition containing the salt thereof as an active ingredient can be used for prevention and treatment of cancer. |
priorityDate | 2013-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 151.